Chronic hyperleptinemia may contribute to various complications of obesity including atherosclerosis, however, the underlying mechanisms are incompletely clear. We examined the effect of leptin on platelet activity by measuring stable metabolites of thromboxane A 2 (TXA 2 ), TXB 2 , 11-dehydro-TXB 2 and 2,3-dinor-TXB 2 , in plasma and urine. In vitro, leptin stimulated TXB 2 formation by platelet-rich plasma (PRP). In vivo, leptin (1 mg/kg ip.) increased urinary excretion of 11-dehydro-TXB 2 and 2,3-dinor-TXB 2 . Urinary excretion of these metabolites was also elevated in rats made hyperleptinemic by administration of recombinant leptin (0.5 mg/kg/day) for 8 days. The stimulatory effect of leptin on TXB 2 formation in PRP isolated from hyperleptinemic animals was impaired in comparison to the control group. In rats made obese, hyperleptinemic and hyperinsulinemic/insulin resistant by cafeteria diet administered for 3 months, acute stimulatory effect of leptin on TXB 2 formation by PRP was not impaired. In rats made insulin resistant by fructose feeding for 8 weeks, stimulatory effect of leptin on TXB 2 formation in PRP was augmented in comparison to the control group. Insulin sensitizer, rosiglitazone, decreased insulin level and attenuated the stimulatory effect of leptin on TXB 2 formation in obese and fructose-fed animals. In contrast, rosiglitazone had no effect on insulin level or leptin-induced TXB 2 formation in control rats and rats receiving recombinant leptin for 8 days. These results indicate that: (i) leptin stimulates platelet TXA 2 formation both in vitro and in vivo, (ii) chronic hyperleptinemia impairs acute stimulatory effect of leptin on platelet activity if insulin sensitivity is normal, (iii) insulin resistance/hyperinsulinemia augments the stimulatory effect of leptin on TXA 2 formation, which results in normal platelet sensitivity to leptin in obesity associated with both hyperleptinemia and hyperinsulinemia, and (iv) PPAR-γ agonists such as rosiglitazone decrease platelet sensitivity to leptin by reducing insulin resistance. 2009; 1: 77-85 
Introduction
Re�e�t st�d�es ��d��ate t�at a� ad�� pose t�ss�e �ormo�e, lept��, �s ��� volved �� at�ero�e�es�s. Plasma lept�� �o��e�trat�o� �s markedly ���reased �� o�ese ��ma�s a�d �� a��mals ��t� o�es�ty ��d��ed �y ������alor�e d�et. �� exper�me�tal st�d�es lept�� �as �ee� demo�strated to �ave ma�y po� te�t�ally proat�ero�e��� effe�ts. Th�s ad�pok��e ��d��es e�dot�el�al dys� f���t�o�, ox�dat�ve stress, vas��lar smoot� m�s�le �ells �ypertrop�y a�d prol�ferat�o�, st�m�lates ma�rop�a�e ��olesterol sy�t�es�s, a�d red��es �DL ��olesterol level (1) . Defi��e��y of lept�� or �ts re�eptor red��e at�ero� s�leros�s �� �lass�� a��mal models s��� as apol�poprote�� � a�d LDL re�eptor k�o�ko�t m��e, ��ereas adm���stra� t�o� of exo�e�o�s lept�� �� s�prap�ys� �olo���al doses or tra�s�e��� �ormo�e overexpress�o� �ave t�e oppos�te ef� fe�t (2) . �� add�t�o�, ma�y �l����al st�d�es ��d��ate t�e l��k �et�ee� ���� lept�� level a�d at�eros�leros�s, a��te �ard�ovas��lar eve�ts a�d �s��em�� stroke �� ��ma�s (3) .
Platelets play a �r���al role �� at�eros�leros�s. Format�o� of platelet� r��� t�rom��s o� t�e r�pt�red plaq�e, ��t� res�lt��� �omplete or almost �omplete vessel o��l�s�o�, �s t�e ma� �or me��a��sm of a��te �ompl��at�o�s of at�eros�leros�s s��� as myo�ard�al ��far�t�o� a�d �s��em�� �ere�ral stroke. �� add�� t�o�, ��ro��� lo���rade platelet a�t�vat�o� fa��l�tates �ro�t� of at�eros�lerot�� plaq�e. Platelets se�rete several med�ators ����� pote�tly st�m�late �ypertrop�y a�d prol�ferat�o� of vas��lar smoot� m�s�le �ells ���l�d��� platelet�der�ved �ro�t� fa�tor a�d t�rom�oxa�e A 2 (TXA 2 ). Moreover, a�t�vated platelets fa� ��l�tate le�ko�yte re�r��tme�t to t�e e�dot�el��m �y se�ret��� ��emota�t�� a�d pro��flammatory med�ators s��� as a ��emok� ��e platelet fa�tor�4, a CD40 l��a�d, P�sele�t��, t�rom�ospo�� d���1 a�d RA�T�S (4) .
The effe�t of lept�� o� platelet f���t�o� �s �o�trovers�al. Some st�d�es �ave demo�strated t�at lept�� a��me�ts ADP���d��ed platelet a��re�at�o� (5) , ��t ot�er a�t�ors o�served �o effe�t (6) . These st�d�es �ere performed in vitro, a�d �t �s �ell�k�o�� t�at platelet a��re�at�o� in vitro �s at �est o�ly a �r�de est�mate of t�e�r f���t�o� �� t�e ��ta�t or�a��sm (7) . Alt�o��� t�e pos�� t�ve �orrelat�o� �et�ee� ser�m lept�� a�d �r��ary ex�ret�o� of TXA 2 meta�ol�te, 11�de�ydro�TXB 2 , �as �ee� o�served �� o�ese �ome� (8) , t��s �orrelat�o� d�sappeared after ad��stme�t for a�� t�ropometr�� var�a�les s���est��� t�at �t represe�ts t�e effe�t of o�es�ty a�d �ot �e�essar�ly of lept�� �tself. �� add�t�o�, res�sta��e to ma�y effe�ts of lept�� �as �ee� des�r��ed �� o�es�ty. �t �s ��� �lear �f platelets' se�s�t�v�ty to lept�� �s preserved or �mpa�red �� o�es�ty. �f platelets rema�� se�s�t�ve to lept��, ��ro��� �yperlep� t��em�a �o�ld �o�tr���te to platelets' �ypera�t�v�ty o�served �� t�e meta�ol�� sy�drome. �o�ever, �f platelets �e�ome res�sta�t to lept��, t�e �o�tr���t�o� of t��s ad�pok��e to at�erot�rom�ot�� �ompl��at�o�s �o�ld �e less l�kely.
To address t�ese �ss�es, �� t�e prese�t st�dy �e exam��ed t�e effe�t of lept�� o� platelet f���t�o�, meas�red as TXA 2 prod��� t�o�, �� t�e rat �ot� in vitro a�d in vivo. �� add�t�o�, �e �om� pared t�e effe�t of lept�� �� lea� a��mals a�d �� sele�ted models of t�e meta�ol�� sy�drome. We also tested t�e effe�t of ros��l�ta� zo�e, a PPAR�γ a�o��st, o� lept�����d��ed TXA2 format�o�.
Materials and methods Animals
All st�d�es �ere performed o� ad�lt male W�star rats �e������ 314 ± 8 �. The a��mals �ere �o�sed ��der �o�trolled �o�d�t�o�s of temperat�re (20�22°C), ��m�d�ty (60�70%), l���t��� (12 � l���t/dark �y�le) a�d prov�ded ��t� food a�d �ater ad libitum. The st�dy proto�ol �as rev�e�ed a�d approved �y t�e lo�al ��� st�t�t�o�al et���al �omm�ttee.
Effect of leptin on TXA 2 production in vitro
Rats �ere a�est�et�zed ��t� pe�to�ar��tal (50 m�/k� �p.) a�d �lood �as ��t�dra�� from t�e a�dom��al aorta �s��� sod��m ��trate as a� a�t��oa��la�t. Blood �as �e�tr�f��ed at 150×� for 15 m�� at a room temperat�re to o�ta�� platelet�r��� plasma (PRP). PRP �as d�l�ted ��t� Tyrode's ��ffer (5 mM ��P�S, 2 mM M�Cl 2 , 0.1% BSA a�d 0.1% D��l��ose) to a sta�dard �o�� �e�trat�o� of 3 × 10 8 platelets/ml. To o�ta�� platelet�poor plasma (PPP), PRP �as re�e�tr�f��ed at 1000 × � for 15 m�� a�d t�e s�per�ata�t �as �olle�ted. PRP �as �����ated ��t� lept�� for 10 m�� a�d TXB 2 �o��e�trat�o� �as meas�red (see �elo�).
Effect of leptin on TXA 2 production in vivo 
Other assays
Plasma ��s�l�� a�d lept�� �o��e�trat�o�s �ere meas�red �y ��A met�ods �s��� Rat ��s�l�� ��A K�t (SP���o, Massy, Fra��e) a�d Lept�� ��zyme �mm��oassay K�t (Cayma� C�em��al), respe�� t�vely (10). L�p�d profile a�d plasma �l��ose �ere assayed �y ro�t��e la�oratory met�ods.
Reagents
Re�om���a�t rat lept�� �as o�ta��ed from R&D Systems. Ros� ��l�tazo�e �as p�r��ased from Cayma� C�em��al. �t�er rea� �e�ts �ere from S��ma�Aldr���.
Statistical analysis
Basel��e (��t�o�t lept��) a�d lept���st�m�lated val�es of TXA 2 meta�ol�tes �� plasma a�d �r��e of t�e same a��mal �ere �om� pared �y repeated�meas�res A��VA. Bet�ee���ro�p �om� par�so�s of TXA 2 meta�ol�tes, plasma l�p�ds, �l��ose, lept�� a�d ��s�l�� �ere do�e �y s���le�meas�res A��VA. P<0.05 �as �o�� s�dered s����fi�a�t.
Results

Leptin stimulates TXA 2 formation in vitro
Lept�� ���reased TXB 2 �o��e�trat�o� �� PRP �solated from �o�� trol lea� rats �� a �o��e�trat�o��depe�de�t ma��er (F��. 1). Lept�� �ad �o s����fi�a�t effe�t at p�ys�olo���al �o��e�trat�o� (10 ��/ml) as �ell as at a moderately elevated �o��e�trat�o� (50 ��/ml), ��t s����fi�a�tly ���reased TXB 2 at 100 ��/ml. Max�mal st�m�latory effe�t of lept�� �as o�served at 300 ��/ml (F��. 1). Add�t�o� of C�X ������tor, ��domet�a��� (10 μM) to t�e �lood �efore �solat�o� of PRP de�reased �asel��e TXB 2 �o��e�trat�o� to 243 ± 29 p�/ml (p<0.001 vs. sample ��t�o�t ��domet�a���) a�d a�ol�s�ed t�e st�m�latory effe�t of lept�� (100 ��/ml lep� t�� + ��domet�a���: 279 ± 31 p�/ml). �� add�t�o�, lept�� �ad �o s����fi�a�t effe�t o� TXB 2 �o��e�trat�o� �� platelet�poor plasma (��t�o�t lept��: 479 ± 57 p�/ml; ��t� 100 ��/ml lept��: 512 ± 53 p�/ml, p=�S).
*** *** ** ** Acute effect of leptin on TXA 2 formation is impaired in hyperleptinemic rats
To exam��e �f ��ro��� �yperlept��em�a ��d��es res�sta��e of platelets to lept��, �e o�ta��ed PRP from rats made �yperlep� t��em�� �y prev�o�s 8�day lept�� adm���strat�o� a�d t�e� st�d� �ed a��te effe�t of lept�� o� TXB 2 format�o� �� t�ese samples �� v�tro (F��. 4). As �a� �e see�, �� �yperlept��em�� rats lept�� s����fi�a�tly st�m�lated TXB 2 format�o� at a �o��e�trat�o� �o less t�a� 300 ��/ml a�d d�d �t to a lesser exte�t t�a� �� �o�trol a��mals at �ot� 300 ��/ml a�d 500 ��/ml. Th�s, a��te st�m�la� tory effe�t of lept�� o� platelet TXA 2 format�o� �s �mpa�red �� �yperlept��em�� rats.
Effect of leptin on TXA 2 formation in obese and fructose-fed rats
To exam��e �f ��ro��� "e�do�e�o�s" �yperlept��em�a asso��ated ��t� o�es�ty �mpa�rs a��te effe�t of lept�� o� TXA 2 format�o�, �e ��vest��ated t�e effe�t of lept�� o� TXB 2 �o��e�trat�o� �� PRP of rats made o�ese �y ������alor�e d�et adm���stered for e�t�er 1 or 3 mo�t�s (F��. 5). Basel��e (��t�o�t exo�e�o�s lep� t��) TXB 2 �o��e�trat�o� �as sl���tly ��t s����fi�a�tly ����er �� t�e 3�mo�t� ��t �ot �� t�e 1�mo�t� o�ese �ro�p. After 10�m�� *** ** *** *** �����at�o�, lept�� (300 ��/ml) ���reased TXB 2 �o��e�trat�o� �� PRP of �o�trol a��mals �y 84.1% ��t �� 1�mo�t� o�ese �ro�p �y o�ly 49.6%. S�rpr�s���ly, �� �o�trast to s�ort�t�me o�es�ty, t�e effe�t of lept�� �� 3�mo�t� o�ese �ro�p �as �ot �mpa�red �� �ompar�so� to t�e �o�trol �ro�p (st�m�lat�o� �y 80.9%). Meta�ol�� ��ara�ter�st��s of �ot� o�ese �ro�ps �s prese�ted �� Ta�le 1. As �a� �e see�, plasma lept�� �s s�m�larly elevated �� �ot� o�ese �ro�ps ��t �� �o�trast to 1�mo�t� �ro�p, t�e 3�mo�t� �ro�p ex����ts �yper��s�l��em�a (a marker of ��s�� l�� res�sta��e) a�d dysl�p�dem�a (�ypertr��ly�er�dem�a a�d lo� �DL���olesterol). ��s�l�� ������ts platelet f���t�o� a�d �ts ef� fe�t �s �mpa�red �� ��s�l�� res�sta��e states (12) . Therefore, �e �ypot�es�zed t�at ��s�l�� res�sta��e �� t�e 3�mo�t� o�ese �ro�p m���t paradox��ally ���rease t�e se�s�t�v�ty of platelets to lept�� �� �ompar�so� to 1�mo�t� o�ese �ro�p. To ver�fy t��s �ypot�� es�s, �e exam��ed t�e effe�t of lept�� �� fr��tose�fed rats, ����� are markedly �yper��s�l��em�� a�d �ypertr��ly�er�dem�� ��t o�ly sl���tly �yperlept��em�� (Ta�le 1). Lept�� (300 ��/ml) ��� �reased TXB 2 �o��e�trat�o� �� PRP of fr��tose�fed a��mals to a m��� �reater de�ree (+153.0%) t�a� �� �o�trol rats. Th�s, fr��� tose���d��ed meta�ol�� sy�drome �s asso��ated ��t� e��a��ed platelet respo�se to lept��. Take� to�et�er, t�ese res�lts s���est t�at �� t�e 3�mo�t� o�ese �ro�p res�sta��e of platelets to lept�� d�e to ��ro��� �yperlept��em�a �s �o��ter�ala��ed �y �o��om�� ta�t �yper��s�l��em�a/��s�l�� res�sta��e ����� ���reases plate� lets' se�s�t�v�ty to t��s ad�pok��e. Rosiglitazone attenuates the effect of leptin on TXA 2 formation in the 3-month obese and fructose-fed rats
To f�rt�er eval�ate t�e a�ove me�t�o�ed �ypot�es�s, �e exam� ��ed t�e effe�t of perox�some prol�ferator�a�t�vated re�eptor�γ (PPAR�γ) a�o��st, ros��l�tazo�e (R�Z), ����� ���reases ��s�l�� se�s�t�v�ty, o� platelet respo�se to lept�� �� var�o�s exper�me�� tal �ro�ps. Ros��l�tazo�e �ad �o effe�t o� plasma lept��, ��s�� l�� a�d l�p�d profile �� e�t�er �o�trol or �yperlept��em�� rats. �� add�t�o�, ros��l�tazo�e d�d �ot alter lept�����d��ed ���rease �� TXB 2 �� PRP of t�ese a��mals (�ot s�o��). �� t�e 3�mo�t� o�ese �ro�p, ros��l�tazo�e �ad �o s����fi�a�t effe�t o� plasma lept�� (��t�o�t R�Z: 12.60 ± 1.27 ��/ml; ��t� R�Z: 10.21 ± 0.98 ��/ml), ��t de�reased plasma ��s�l�� (from 3.89 ± 0.46 to 2.57 ± 0.29 ��/ml, p<0.01) a�d tr��ly�er�des (from 1.20 ± 0.08 to 0.74 ± 0.05 mM, p<0.01). Basel��e (��t�o�t exo�e�o�s lept��) TXB 2 �o��e�trat�o� �as lo�er �� R�Z�treated t�a� �� �o��treated 3�mo�t� o�ese rats (571 ± 27 vs. 693 ± 39 p�/ml, p<0.05). �� add�t�o�, lept�� (300 m�/ml) ���reased TXB 2 �o��e�trat�o� �� R�Z�treated o�ese rats to 878 ± 87 p�/ml (+53.8%), ����� �s s����fi�a�tly less t�a� �� e�t�er �o�trol or R�Z���treated o�ese a��mals. �� t�e fr��tose�fed �ro�p, R�Z de�reased plasma ��s�� l�� (�54.6%) a�d tr��ly�er�des (�41.7%) a�d red��ed t�e st�m�la� tory effe�t of 300 ��/ml lept�� o� TXB 2 from +153.0% (p<0.01 vs. �o�trol �ro�p) to +79.4% (p=�S vs. �o�trol �ro�p).
Discussion
Meta�ol�� sy�drome �s asso��ated ��t� ���reased r�sk of arter�al a�d ve�o�s t�rom�os�s (13�15). The pat�o�e�es�s of prot�rom� �ot�� state �� t�e meta�ol�� sy�drome �s �omplex a�d ���om� pletely ��derstood. ���reased �o��e�trat�o� of some �oa��lat�o� fa�tors s��� as fi�r��o�e�, fa�tor V�� a�d t�ss�e fa�tor, defi��e��y of a ma�or a�t�vator of fi�r��olys�s, t�ss�e plasm��o�e� a�t�vator, a�d ex�ess of fi�r��olys�s ������tor, plasm��o�e� a�t�vator ������ �tor�1 (PA��1) �ave �ee� reported �� pat�e�ts ��t� over�e���t/ o�es�ty. �� add�t�o�, platelet a��re�at�o� �s a��me�ted �� o�ese a��mals a�d ��ma�s (16) , as ev�de��ed �y ���reased ADP���� d��ed platelet a��re�at�o� (6), ����er �r��ary 11�de�ydro�TXB 2 ex�ret�o� (8), plasma P�sele�t�� (17) a�d sol��le CD40 l��a�d levels (18) . Platelets of o�ese s���e�ts are res�sta�t to ������tory effe�ts of prosta�y�l�� a�d ade�os��e (����� elevate ��tra�ell�lar �AMP) a�d ��tr�� ox�de (����� elevates ��tra�ell�lar ��MP), as �ell as to t�ese �y�l�� ���leot�des t�emselves (19, 20) . Moreo� ver, meta�ol�� sy�drome �s asso��ated ��t� red��ed se�s�t�v�ty of platelets to at least t�o �ro�ps of a�t�platelet dr��s, a�etyl� sal��yl�� a��d a�d PY 12 re�eptor ������tors, t��e�opyr�d��es (21) . ���reased e�dot�el�al �ell�platelet ��tera�t�o� �as �ee� o�served �� v�s�eral ad�pose t�ss�e �� m�r��e models of o�es�ty (22) .
Several st�d�es �ave demo�strated t�at lept�� a��me�ts ADP�, t�rom���� or �olla�e����d��ed platelet ad�es�o� a�d/or a��re�at�o� �� v�tro (5, 23, 24) . �� add�t�o�, exo�e�o�s lept�� adm���stered to ��ld�type m��e a��me�ted vas��lar t�rom�os�s ��d��ed �y vessel �all ����ry (25, 26) . �� t�e prese�t st�dy �e exam��ed t�e effe�t of lept�� o� TXA 2 format�o� �ot� �� v�tro a�d �� v�vo. TXA 2 �s o�e of t�e most �ommo� platelet a�o��sts, a�d t�e most ��dely pres�r��ed a�t�platelet dr��, a�etylsal��yl�� a��d, red��es platelet a�t�v�ty �y ������t��� �ts sy�t�es�s. Apart from st�m�lat��� platelets, TXA 2 �s ��volved �� at�ero�e�es�s �y ��d����� vas��lar smoot� m�s�le �ell m��rat�o� a�d prol�fera� t�o� (27) a�d express�o� of ad�es�o� mole��les �� e�dot�el�al �ells (28) . To t�e �est of o�r k�o�led�e, o�ly o�e prev�o�s st�dy ��es�ty �s asso��ated ��t� res�sta��e �ot o�ly to �e�tral a�ore�t�� ��t also to some per�p�eral effe�ts of lept�� (30) , ����� part�ally res�lts from do��re��lat�o� of lept�� re�eptors a�d/ or postre�eptor s���al��� me��a��sms d�e to ��ro��� �yperlep� t��em�a (31) . �t �s �o�trovers�al �f platelets of o�ese ��d�v�d�als rema�� se�s�t�ve to lept�� or �e�ome lept���res�sta�t. Corso�ello et al (32) �ave demo�strated t�at st�m�latory effe�t of lept�� o� platelet a��re�at�o� �s �mpa�red �� over�e���t a�d o�ese ��d�� v�d�als. �� �o�trast, Cor��a et al (33) fo��d t�at lept�����d��ed platelet a��re�at�o� �as �mpa�red o�ly �� mor��dly o�ese ��t �ot �� over�e���t s���e�ts, a�d Dellas et al (34) o�served �or� mal platelet se�s�t�v�ty to lept�� �� mor��dly o�ese pat�e�ts �� �ompar�so� to �ormal��e���t �o�trols. �ere�� �e demo�strate t�at �ot� �yperlept��em�a ��d��ed �� lea� rats �y adm���stra� t�o� of exo�e�o�s lept�� a�d "e�do�e�o�s" �yperlept��em�a �� 1�mo�t� o�ese �ro�p are asso��ated ��t� res�sta��e to a��te TXA 2 �st�m�lat��� effe�t of lept�� in vitro. Desp�te t��s res�st� a��e, �r��ary TXA 2 meta�ol�tes are elevated �� �yperlept��em�� rats. These res�lts ��d��ate t�at lept�� may st�ll �o�tr���te to platelet �ypera�t�v�ty ��e� �ormo�e level �s markedly elevated, alt�o��� t�e de�ree of platelet st�m�lat�o� �s ��do��tedly lo�er t�a� �o�ld �ave �ee� �f platelets rema��ed lept���se�s�t�ve.
S�rpr�s���ly, res�sta��e to lept�� �as �ot o�served �� t�e 3�mo�t� o�ese �ro�p, alt�o��� e�do�e�o�s lept�� level te�ded to �e ����er �� t�ese a��mals t�a� �� t�e 1�mo�t� o�ese �ro�p. We �ypot�es�ze t�at desp�te poss��le do��re��lat�o� of lept�� s���al���, lept�����d��ed TXA 2 prod��t�o� �s a��me�ted �y �o��om�ta�t ��s�l�� res�sta��e �� t�ese a��mals. Th�s �ypot�� es�s �s s�pported �y t�e follo���� o�servat�o�s: (�) o�ly 3�mo�t� o�ese rats �ere �yper��s�l��em�� (a�d t��s pres�ma�ly ��s�� l�� res�sta�t), (��) platelet se�s�t�v�ty to lept�� �as a��me�ted �� fr��tose�fed rats ����� �ere markedly ��s�l�� res�sta�t ��t relat�vely �ormolept��em��, (���) ros��l�tazo�e de�reased ��s�� l�� level a�d platelets' respo�se to lept�� �� t�e 3�mo�t� o�ese a�d fr��tose�fed ��t �ot �� e�t�er �o�trol or �yperlept��em�� �ro�ps, a�d (�v) ��s�l�� ������ts platelet f���t�o� a�d �ts effe�t �s �mpa�red �� t�e meta�ol�� sy�drome (12, 19, 35) . �evert�eless, ot�er expla�at�o�s �a��ot �e defi��tely ex�l�ded. For example, �yperl�p�dem�a promotes platelet a��re�at�o� (36) , a�d �ot� 3�mo�t� o�ese a�d fr��tose�fed a��mals �ere �yperl�p�dem��. �� add�t�o�, ros��l�tazo�e �ot o�ly red��ed ��s�l�� level ��t also �mproved l�p�d profile. W�atever t�e me��a��sm, t�e res�lts s���est t�at PPAR�γ a�o��sts s��� as ros��l�tazo�e may �e�efi� ��ally mod�late platelet f���t�o� �� o�es�ty/meta�ol�� sy�drome �y red����� t�e�r se�s�t�v�ty to lept��. �� add�t�o�, var�a�le de� �ree of ��s�l�� res�sta��e may determ��e platelets' se�s�t�v�ty to lept�� �� o�ese s���e�ts a�d may expla��, at least part�ally, �o�� trovers�al res�lts of prev�o�s st�d�es �� t��s field (32�34).
��terest���ly, �r��ary TXB 2 ex�ret�o� �as ���reased �� t�e �yperlept��em�� �ro�p. ���reased ��trare�al TXA 2 prod��t�o� may �o�tr���te to t�e developme�t of arter�al �yperte�s�o� a�d �ep�ropat�y d�e to �ts vaso�o�str��t���, a�t��atr��ret�� a�d profi�ro�e��� effe�ts. ���reased �r��ary TXB 2 ex�ret�o� �as o�� served �� ma�y a��mal models of �yperte�s�o� s��� as spo�� ta�eo�sly �yperte�s�ve rat, Da�l salt�se�s�t�ve rat, fr��tose� or �� sy�t�ase ������tor���d��ed �yperte�s�o� as �ell as �� o�ese Z��ker rats ����� develop severe �ep�ropat�y (37�39). C�ro��� lept�� adm���strat�o� ��d��es arter�al �yperte�s�o� (9) a�d may ��d��e �ep�ropat�y (40�41). �t rema��s to �e esta�l�s�ed �f ex� �ess�ve ��trare�al TXA 2 format�o� �o�tr���tes to t�ese lept��� ��d��ed �ompl��at�o�s.
There are several l�m�tat�o�s of t�e prese�t st�dy. F�rst, �e meas�red o�ly TXA 2 format�o� a�d d�d �ot assess platelet f���� t�o� d�re�tly. TXA 2 format�o� �s a� esta�l�s�ed marker of platelet f���t�o� a�d allo�ed �s to exam��e �t �ot� �� v�tro a�d �� v�vo �� t�e same exper�me�tal model. Se�o�d, �e exam��ed t�e effe�t of lept�� alo�e a�d d�d �ot address �ts ��tera�t�o� ��t� ot�er plate� let a�o��sts. Th�rd, a��tely adm���stered lept�� ���reases �atr��� res�s (42, 43) . �t �o�ld �e s���ested t�at lept�� ���reased �r��ary 11�de�ydro�TXB 2 a�d 2,3�d��or�TXB 2 se�o�dar�ly to ���reas��� sod��m ex�ret�o�. Th�s poss���l�ty seems, �o�ever, ��l�kely for t�e follo���� reaso�s: (�) �� �o�trast to 11�de�ydro�TXB 2 a�d 2,3�d��or�TXB 2 , a��tely adm���stered lept�� �ad �o effe�t o� TXB 2 ex�ret�o�, (��) 8�day �yperlept��em�a �s asso��ated ��t� ��� �reased ex�ret�o� of TXA 2 meta�ol�tes ��ereas �atr��res�s �s re� d��ed �� t��s model (9) , a�d (���) f�rosem�de ���reased �atr��re� s�s ���le �av��� �o effe�t o� �r��ary TXA 2 meta�ol�tes, ��ereas C�X ������tor, ��domet�a���, preve�ted lept�����d��ed ���rease �� TXA 2 meta�ol�tes ��t �ad �o effe�t o� lept�����d��ed ���rease �� �atr��res�s (��p��l�s�ed o�servat�o�).
�� �o��l�s�o�, �e �ave demo�strated t�at �ot� a��tely a�d ��ro���ally adm���stered lept�� ���reases TXA 2 format�o� �� t�e rat. C�ro��� �yperlept��em�a �mpa�rs platelets' respo�se to a��tely adm���stered lept�� �f ��s�l�� se�s�t�v�ty �s �ormal, �o�� ever, t�e st�m�latory effe�t of lept�� �s ��ta�t �f ��s�l�� res�sta��e �s �o��om�ta�tly o�served. PPAR�γ a�o��sts may �e �sef�l as ad����t�ve a�t�platelet t�erapy �� o�es�ty/meta�ol�� sy�drome �e�a�se t�ey red��e platelets' se�s�t�v�ty to lept�� �y amel�orat� ��� ��s�l�� res�sta��e.
